5.4 million Americans are currently diagnosed with Alzheimer’s disease – the most common cause of dementia and the 6th leading cause of death in the United States. The prevalence of Alzheimer’s is rapidly rising and by the year 2050 it is estimated that the number of Americans over the age of 65 suffering from this tragic illness will grow from 5.2 to 13.8 million. To put this into even greater perspective, every 66 seconds, someone in the US develops Alzheimer’s. What’s even more devastating is the significant toll this life-altering disease has on not just the lives of the patients, but on that of the family, loved ones, and caregivers…nearly 60 percent of caregivers rate the associated emotional distress as high and approximately 40 percent suffer from depression. These alarming statistics and with the total economic costs projected to be $236 billion in 2016, Alzheimer’s and other forms of dementia are a major public health concern, further emphasizing the urgency for discovering successful and effective forms of prevention and treatment.
Over the last decade, researchers have brought forth a wealth of new information and knowledge with regards to early detection of Alzheimer’s, providing hope for the future of this debilitating disease. Accordingly, brain changes caused by Alzheimer’s have been found to begin as early as 20 years or more prior to the onset of the first symptoms. During these initial alterations, the brain compensates for the damage, allowing individuals to continue to function normally. In turn, the possibility of early detection is critical and could potentially alleviate some of the long-term psychological and financial burden on individuals and families who engage in early preparation.
However, as the years pass and the neuronal damage increases, the brain is no longer able to compensate, and the individual begins to demonstrate subtle shifts in cognitive abilities. Although symptoms vary on a case-by-case basis, the most common and primary symptom is difficulty recalling new information, as the initial damage occurs in localized regions of the brain responsible for forming new memories. As the disease begins to take its course and the neuronal damage becomes more widespread across other areas of the brain, individuals may experience the following symptoms: memory loss, challenges in planning or problem solving, trouble completing familiar tasks, disorientation with time and place, misplacing and losing items, poor judgment, difficulty understanding visual images and spatial relationships, withdrawal from personal and professional activities, changes in mood and personality (including apathy and depression), and increased anxiety, agitation, and sleep disturbance. In the final stage and most difficult stage of the disease, individuals require around the clock assistance with daily personal care, lose the ability to respond to their environment, even experience a loss in the ability to walk, sit, and swallow, amongst other debilitating symptoms.
No single, simple test will diagnose dementia caused by Alzheimer’s (or any other form of dementia for that matter), rather, a team of physicians including a neurologist, neuropsychologist, and radiologist typically work alongside the primary care physician to determine the pathology and course of the disease. The unfortunate reality is that once diagnosed, none of the treatments available to date have the ability to slow down or stop the progressive neuronal damage that occurs as a result of Alzheimer’s.
Alzheimer’s is the ONLY disease among the top 10 causes of death in the US that cannot be prevented, cured or even slowed…UNTIL NOW! H2 has shown promising results in treating and preventing various neurodegenerative diseases including Alzheimer’s, Parkinson’s, and CTE, amongst others. Until recently, the earliest detection of Alzheimer’s was the accumulation of an abnormal form of proteins known as tau and Aβ (beta-amyloid plaques) – contributing to the brain changes which cause destruction of the neurons, resulting in the memory decline and other symptoms of Alzheimer’s. Recent studies published in 2016 have found a new target for the diagnosis and treatment of Alzheimer’s, stating that mitochondrial injury and dysfunction precedes the accumulation of abnormal proteins. As such, reducing this mitochondrial injury may serve as a preventative measure and diminish the onset of and severity of symptoms associated with Alzheimer’s.
With that being said…Over 700 peer-reviewed, scientific articles have demonstrated the vast array of health benefits from drinking hydrogen-enriched water (H2 water). Specifically with regards to neurodegenerative diseases, including Alzheimer’s, studies have shown that drinking hydrogen rich water completely BLOCKED the detection of the tau protein. Additionally, neuroinflammation is another common characteristic of the pathology of Alzheimer’s and other neurodegenerative diseases, and H2 has further been evident to modulate such neuroinflammation. Furthermore, and probably most exciting, molecular hydrogen’s low weight and structure enables penetration of any membrane/compartment of our body – allowing it to cross into the mitochondria and prevent free radical and oxidative damage that precedes the neuronal damage underlying Alzheimer’s!
Ultimately, molecular hydrogen not only alleviates the vast majority if not all of the symptoms, it addresses the root cause of the symptoms. H2 is the ONLY known treatment that has the power to stop the progression of the disease process. Finally…a simple, safe, and effective therapy that will enable you to live a long, healthy, and happy life alongside your loved one.